Infectious Complications the Year after Autologous Bone Marrow Transplantation or Peripheral Stem Cell Transplantation for Treatment of Breast Cancer
Open Access
- 1 February 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (3) , 391-395
Abstract
Few studies have examined the specific incidence of infections after autologous bone marrow transplantation (BMT) or peripheral stem cell transplantaKeywords
This publication has 7 references indexed in Scilit:
- Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.Journal of Clinical Oncology, 1996
- Antimicrobial Prophylaxis in Bone Marrow TransplantationAnnals of Internal Medicine, 1995
- Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.Journal of Clinical Oncology, 1995
- Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.Journal of Clinical Oncology, 1994
- Herpes zoster infection after autologous bone marrow transplantationBlood, 1989
- Analysis of early infectious complications after autologous bone marrow transplantationCancer, 1988
- Problems of infection after bone marrow transplantation.Journal of Clinical Pathology, 1983